BiotechTube
Home/Pipeline/TSO500 Cancer Panel

TSO500 Cancer Panel

Solid Tumors

ClinicalActive

Key Facts

Indication
Solid Tumors
Phase
Clinical
Status
Active
Company
Genomics BioSci & Tech

About Genomics BioSci & Tech

Taiwan’s leading full‑service genomics and CDMO provider delivering sequencing, synthesis, and clinical testing solutions.

View full company profile

Therapeutic Areas

OncologyGenetic DisordersReproductive Health

Other Solid Tumors Drugs

DrugCompanyPhase
APVO603Aptevo TherapeuticsPreclinical
APVO711Aptevo TherapeuticsPreclinical
Platform-derived ImmunotherapyGenCirqPre-clinical
SP-2-225Shuttle PharmaceuticalsPreclinical
SP-1-161Shuttle PharmaceuticalsPreclinical
CAR-T Solid Tumor ProgramCarina BiotechPhase 1/2a
HBM1020Harbour BioMedPhase 1
HBM7022Harbour BioMedPhase 1
HBM9033Harbour BioMedDiscovery
Undisclosed Whole Cell Vaccine Program(s)NeuvogenPre-clinical
SY-5609Syros PharmaceuticalsPhase 1/2
Not Specified (TCR Therapy)T-Cure BiosciencePhase 1